Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 70

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 70
---
200,000

    200,000

    1,092,569

    1,092,572

    (1)
    Warrants will be exercisable beginning on the date of stockholder approval of the exercisability of the warrants under Nasdaq rules. Once exercisable, the warrants will expire on the five-year anniversary of the date of such stockholder approval.

Stock Compensation

2015 Equity Incentive Plan

In April 2015, the Company adopted, and the Company’s stockholders approved, the 2015 Equity Incentive Plan (the “2015 Plan”); the 2015 Plan became effective upon the execution and delivery of the underwriting agreement for the Company’s initial public offering in May 2015. The 2015 Plan provides for the granting of incentive stock options within the meaning of Section 422 of the Code to employees and the granting of non-qualified stock options to employees, non-employee directors and consultants. The 2015 Plan also provides for the grant of restricted stock, restricted stock units, stock appreciation rights, dividend equivalents and stock payments to employees, non-employee directors and consultants. Effective April 1, 2025, which is the ten (10) year anniversary of the adoption of the 2015 Plan, no additional grants may be made under the 2015 Plan.

    19

Stock Options

For
the three and six months ended June 30, 2025 and 2024, the Company recognized share-based compensation expense as follows: 

    Schedule of company recognized stock compensation expense

    Three Months Ended June 30,

    Six Months Ended 
June 30,

    2025

    2024

    2025

    2024

    Cost of services
     
    $
    -

    $
    -

    $
    -

    $
    -

    Research and development

    -

    22,964

    -

    48,820

    General and administrative

    101,250

    345,427

    182,958

    503,411

    Sales and marketing

    -

    -

    -

    4,397

    $
    101,250

    $
    368,391

    $
    182,958

    $
    556,628

No income tax benefit for share-based compensation arrangements was recognized in the unaudited condensed consolidated statements of operations and comprehensive income (loss)